Covered recipient · General Payments record
BRANDY LEE LARSON
Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology
General Payments · PY2021–2024
$2,127.15
- Reported across 113 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $754.21 | 29 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $259.37 | 16 |
| Daiichi Sankyo Inc. | $159.23 | 3 |
| Amgen Inc. | $124.99 | 1 |
| Astellas Pharma US Inc | $90.13 | 3 |
| Celgene Corporation | $32.69 | 1 |
| Novo Nordisk AS | $30.49 | 2 |
| Lilly USA, LLC | $22.53 | 1 |
| Medtronic, Inc. | $20.87 | 1 |
| PFIZER INC. | $13.91 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (29)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.84 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511155 | CMS |
| ABBVIE INC. | $6.52 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511157 | CMS |
| ABBVIE INC. | $14.38 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511159 | CMS |
| ABBVIE INC. | $22.46 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511161 | CMS |
| ABBVIE INC. | $10.87 | 02/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511163 | CMS |
| ABBVIE INC. | $15.76 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511165 | CMS |
| ABBVIE INC. | $19.31 | 03/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511167 | CMS |
| ABBVIE INC. | $10.33 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511169 | CMS |
| ABBVIE INC. | $30.99 | 05/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511171 | CMS |
| ABBVIE INC. | $12.64 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511173 | CMS |
| ABBVIE INC. | $16.32 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511175 | CMS |
| ABBVIE INC. | $5.48 | 07/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511177 | CMS |
| ABBVIE INC. | $18.51 | 08/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511179 | CMS |
| ABBVIE INC. | $23.36 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511181 | CMS |
| ABBVIE INC. | $7.84 | 09/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511183 | CMS |
| ABBVIE INC. | $26.76 | 10/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107511185 | CMS |
| Amgen Inc. | $124.99 | 02/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117606886 | CMS |
| Astellas Pharma US Inc | $31.83 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139501452 | CMS |
| Astellas Pharma US Inc | $30.63 | 06/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139520401 | CMS |
| Astellas Pharma US Inc | $27.67 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139557109 | CMS |
| Celgene Corporation | $32.69 | 02/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101115034 | CMS |
| Daiichi Sankyo Inc. | $17.53 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089446884 | CMS |
| Daiichi Sankyo Inc. | $16.71 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089446860 | CMS |
| Daiichi Sankyo Inc. | $124.99 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089446866 | CMS |
| Lilly USA, LLC | $22.53 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135553267 | CMS |
| Medtronic, Inc. | $20.87 | 12/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116890985 | CMS |
| Novo Nordisk Inc | $14.56 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100576486 | CMS |
| Novo Nordisk Inc | $15.93 | 10/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100550190 | CMS |
| PFIZER INC. | $13.91 | 01/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131175044 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.